Form D · Other Technology

Javelo Health Ltd

Edinburgh, X0 · CIK 0001990266

Offering snapshot reported Apr 21, 2025 · SEC filing

Reported sold
$1.97M
Offering amount: $2.56M
Investors reported
8
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Mar 25, 2025
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$987K$1.97MApr 8, 2025: $1,974,014.00Apr 8, 2025Apr 21, 2025: $1,974,014.00Apr 21, 2025

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Apr 21, 2025Amendment$1,974,014$0vs Apr 8, 20258SEC filing
Apr 8, 2025Initial$1,974,014No comparison8SEC filing
Aug 23, 2023Initial$1,250,508No comparison19SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-543172

Source: Form D, filed Apr 21, 2025. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Ashton Barnett Vanes Director
Alan Finnerty Director
Elaine Harrington Warburton Director
Elaine Harrington Warburton Obe Director

Issuer details

Industry: Other Technology (See others in industry)

Address:
Suite 2, Ground Floor Orchard Brae House 30 Queensferry Road
Edinburgh, X0, EH4 2HS